Product Commercialised

A technology related to “Collagen based formulation for treatment of osteoarthritis  related symptoms”, is transferred to Purobien Lifesciences Pvt Ltd for commercialization on 22.02.2021. The product with the Brand name UJC (ultimate  joint care) is now available in the market. 

Technology Transfer:  

1. A technology related to “Collagen-based formulation for the treatment of  osteoarthritis-related symptoms”, is transferred to Purobien Lifesciences Pvt Ltd for  commercialization on 22.02.2021. 

2. Composition useful for the treatment of inflammatory disease or disorders (2011),  Extended Delivery Pharmaceuticals, LLC, U.S.A. 

3. Composition useful for treatment of diabetes & chronic disorder (2010), Extended  Delivery Pharmaceuticals, LLC, U.S.A. 

4. Novel compounds modulating GSK3 activity, (2023) option agreement signed with  Bridge Consultancy/ FDA-MAP, USA